Revised Financial Guidance

Cupid Limited has significantly raised its full-year FY27 financial guidance based on strong Q2 performance and improved business visibility:

  • FY27 Revenue Guidance: Revised upward to ₹800+ Crore
  • FY27 Net Profit Guidance: Revised upward to ₹250+ Crore
  • Q2 FY27 Revenue: Expected to cross ₹200 Crore

The upward revision is supported by sustained momentum across key business verticals, improved visibility across domestic and international markets, continued expansion of domestic FMCG business, progress towards operationalization of the Palava facility, and sustained growth across healthcare and personal care portfolios.

Operational Highlights

Investment Activity:

  • Approved conversion of up to 30 lakh warrants of Baazar Style Retail Limited into equity shares at ₹328.25 per share

International Expansion:

  • Received in-principle approval for manufacturing venture in South Africa
  • South African initiative will adopt asset-light model combining Cupid's manufacturing expertise with local partner support
  • Facility aims to support local manufacturing and create platform for expansion across Africa and international markets

Strategic Partnerships:

  • Strengthened strategic healthcare partnership with GII Healthcare Investment Limited through additional USD 5 million follow-on investment

Business Development:

  • Continued strengthening of healthcare and Personal Care platform with expanding FMCG portfolio and manufacturing capabilities
  • Strengthened capital market position with inclusion in BSE Group 'A', NIFTY Small Cap 250, and FTSE Emerging Markets All Cap Index

Forward-Looking Strategic Initiatives

Domestic Market Expansion:

  • Scale domestic FMCG distribution to deepen presence across modern trade, general trade, and pharmacy channels

Manufacturing Capacity:

  • Operationalize the Palava manufacturing facility to enhance production capacity, flexibility, and supply capabilities

Product Portfolio:

  • Expand healthcare and personal care portfolio through new products, regulatory approvals, and wider commercialization opportunities

International Business:

  • Strengthen international healthcare business by expanding institutional, government, and private-market opportunities
  • Build regional manufacturing platforms through proposed South African venture
  • Explore strategic healthcare opportunities through partnerships and investments

Company Background

Established in 1993, Cupid Limited is one of Bharat's leading healthcare and Personal care companies engaged in manufacturing and marketing of:

  • Male and female condoms
  • Water-based personal lubricants
  • IVD kits
  • Consumer Healthcare & FMCG products

Consumer Portfolio Includes:

  • Fragrance products (Eau De Parfums, Deodorants, Pocket Perfumes)
  • Personal care products (Hair Removal Sprays, Face Wash, Hair & Body Oils, Toilet Sanitizers)
  • IVD kits and personal lubricants

Market Presence:

  • Domestic: Expanding network across modern trade, organised retail, and pharmacy channels
  • International: Exports to 125+ countries
  • First company in the world to receive WHO/UNFPA prequalification for both male and female condoms
  • Serves diversified global customer base through PFSCM, WHO/UNFPA, institutional procurement programmes, government tenders, and private export markets